1. Predicting Persistent Disabling Low Back Pain in Veterans Affairs Primary Care Using the STarT Back Tool
- Author
-
Gang Luo, Daniel C. Cherkin, Pradeep Suri, Samuel L. Battalio, Anna Korpak, Sean D. Rundell, and Jacob Kneeman
- Subjects
Predictive validity ,030506 rehabilitation ,medicine.medical_specialty ,Psychological intervention ,MEDLINE ,Physical Therapy, Sports Therapy and Rehabilitation ,Primary care ,Cohort Studies ,03 medical and health sciences ,Disability Evaluation ,0302 clinical medicine ,health services administration ,medicine ,Humans ,Veterans Affairs ,health care economics and organizations ,Pain Measurement ,Veterans ,Primary Health Care ,business.industry ,Rehabilitation ,Low back pain ,nervous system diseases ,Neurology ,Physical therapy ,population characteristics ,Female ,Neurology (clinical) ,Medium Risk ,medicine.symptom ,0305 other medical science ,business ,Low Back Pain ,030217 neurology & neurosurgery ,Cohort study - Abstract
Introduction The Subgrouping for Targeted Treatment (STarT Back) is a stratified care approach to LBP treatment. The predictive validity of STarT Back in Veterans Affairs (VA) primary care has not been demonstrated. Objective To examine the validity of the STarT Back tool for predicting future persistent disabling LBP in VA primary care. Design Cohort study. Setting VA primary care in Washington State. Participants Veterans seeking care for LBP in VA primary care clinics. Interventions Not applicable. Main outcome measures The STarT Back tool was used to classify Veterans according to their baseline risk group (low vs medium vs high). The primary study outcome, persistent disabling LBP, was defined as a Roland-Morris Disability Questionnaire (RMDQ) score ≥ 7 at 6-month follow-up. Analyses examined discrimination and calibration of the baseline STarT Back risk groups for prediction of persistent disabling LBP at 6-month follow-up. Results Of the study sample, 9% were females and 80% reported longstanding LBP (>5 year duration). Among 538 participants, the baseline STarT Back risk groups were associated with future persistent disabling LBP at 6-month follow-up. Within each baseline STarT Back risk group, the proportions with future persistent disabling LBP at 6-month follow-up were 54% (low risk), 88% (medium risk), and 97% (high risk). The baseline STarT Back risk groups had useful discrimination (area under the curve [AUC] 0.79) for predicting future persistent disabling LBP, but the proportion of Veterans persistent disabling LBP at 6-month follow-up was substantially higher than that observed in non-VA primary care settings. Conclusions The STarT Back risk groups had useful discrimination (AUC = 0.79) for future persistent disabling LBP, but calibration was poor, underestimating the risk of persistent disabling LBP. The STarT Back tool may require updating for use in VA primary care. This article is protected by copyright. All rights reserved.
- Published
- 2020